1[1]Small E. J Prostate Cancer:Incidence,Management and Outcomes[J].Drugs & Aging, July 1998,13(1):71～81.
2[2]PollardM, WolterWR, Sun L. Prostate-seminal vesicle cancers induced in noble rats[J] .Prostate.2000,43:71 ～ 74.
3[3]Huss WJ, Maddison LA, Greenberg NM. Autochthonous mouse models for prostate cancer: past, present and future[J]. Semin Cancer Biol,2001,11:245～260.
4[4]Brothman AR, Maxwell TM, Gui J, et al. Chromosomalcluuse to the development of prostate tumors[J]. Prostate, 1999 Mar 1,38(4):303～312.
5[5]Gingrich J, Barrios R,Foster B,Greenberg N.Pathologic provon of autochthonous prostate cancer in the TRAMP mode[ J ]. Prostate Cancer ProstaticDis 1999,2:270 ～ 275.
6[6]Garabedian EM, Humphrey PA, Gordon JI. A transgenic mouse model of metastatic prostate cancer originating from neuroendiocrine cells[ J] .Proc Natl Acad Sci USA 1998,95:15382～ 15387.
7[7]Foster BA, Greenberg NM. New model of bone metastasis for prostate cancer:cell lines derived from a bonemetastasis in TRAMP[J]. Proc Am Assoc Cancer Res.2001,42:140.
8[8]Shevrin DH, Kukreja SC, Ghosh L, Lad TE. Development of skeletal metastasis by human prostate cancer in athymic nude mice [ J ]. Clin Exp Metastasis. 1988 Sep- Oct;6(5):401～9.
9[9]Thalmann GN, Anezinis PE, Chang SM, et al. Androgen - independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer[J]. Cancer Res. 1994 May 15;54(10) :2577 ～ 81.
10[10]Wu TT, Sikes RA, Cui Q, Thalmann GN, et al. Establishing human prostate cancer cell xenografts in bone:induction of osteoblastic reaction by prostate - specific antigen - producing tumors in athymic and SCID/bg mice using LNCaP and lineage - derived metastatic sublines[J]. Int J Cancer. 1998 Sep11 ;77(6) :887 ～ 94.
4Thalmann GN,Anezinis PE,Chang SM,et al.Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer[J].Cancer Res,1994,54 (10):2577-2581.
5Wu TT,Sikes RA,Cui Q,et al.Establishing human prostate cancer cell xenografts in bone induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/ bg mice using LNCaP and lineage-derived metastatic sublines[J].Int J Cancer,1998,77 (6):887-894.
6Radbani SA,Gladu J,Harakidas P,et al.Over-production of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells in vivo[J].Int J Cancer,1999,80(2):257-264.
7Corey E,Quinn JE,Bladou F,et al.Establishment and characterization of osseous prostate cancer models:intra-tibial injection of human prostate cancer cells[J].Prostate,2002,52(1):20-33.
8Fisher JL,Schmitt JF,Howard ML,et al.An in vivo model of prostate carcinoma growth and invasion in bone[J].Cell Tissue Res,2002,307(3):337-345.
9Andresen C,Bagi CM,Adams SW.Intra-tibial injection of human prostate cancer cell line CWR22 elicits osteoblastic response in immunodeficient rats[J].J Musculoskelet Neuron Interact,2003,3 (2):148-155.
10Small EJ.Prostate cancer:incidence,management and outcomes[J].Drugs Aging,1998,13(1):71-81.
